CompoSecure (CMPO)
(Delayed Data from NSDQ)
$6.77 USD
-0.73 (-9.73%)
Updated May 9, 2024 04:00 PM ET
After-Market: $6.78 +0.01 (0.15%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Income Statements
Fiscal Year end for CompoSecure, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 391 | 378 | 268 | 0 | 243 |
Cost Of Goods | 182 | 159 | 123 | 0 | 115 |
Gross Profit | 209 | 220 | 145 | 0 | 128 |
Selling & Adminstrative & Depr. & Amort Expenses | 90 | 105 | 63 | 0 | 41 |
Income After Depreciation & Amortization | 119 | 115 | 81 | 0 | 87 |
Non-Operating Income | 21 | 41 | 11 | 0 | -1 |
Interest Expense | 23 | 20 | 10 | 0 | 5 |
Pretax Income | 117 | 136 | 83 | 0 | 81 |
Income Taxes | 5 | 4 | -1 | 0 | 0 |
Minority Interest | 93 | 113 | 70 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 113 | 132 | 83 | 0 | 81 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 19 | 19 | 14 | 0 | 81 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 129 | 126 | 94 | 0 | 96 |
Depreciation & Amortization (Cash Flow) | 10 | 11 | 12 | 0 | 9 |
Income After Depreciation & Amortization | 119 | 115 | 81 | 0 | 87 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 35.31 | 32.56 | 94.93 | NA | NA |
Diluted EPS Before Non-Recurring Items | 0.97 | 0.94 | 0.14 | NA | NA |
Diluted Net EPS (GAAP) | 0.96 | 1.13 | 0.14 | -0.03 | NA |
Fiscal Year end for CompoSecure, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 99.90 | 96.89 | 98.53 | 95.32 |
Cost Of Goods | NA | 47.00 | 47.99 | 44.59 | 41.96 |
Gross Profit | NA | 52.89 | 48.90 | 53.94 | 53.35 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 22.37 | 20.10 | 23.59 | 23.94 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 30.52 | 28.80 | 30.35 | 29.41 |
Non-Operating Income | NA | 9.88 | 15.89 | 8.77 | -14.01 |
Interest Expense | NA | 5.48 | 5.70 | 5.44 | 5.93 |
Pretax Income | NA | 34.92 | 39.00 | 33.68 | 9.47 |
Income Taxes | NA | 3.90 | 0.95 | 0.97 | -1.26 |
Minority Interest | NA | 27.33 | 30.57 | 26.97 | 8.41 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 31.02 | 38.05 | 32.71 | 10.74 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 3.70 | 7.48 | 5.74 | 2.33 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 19.38 | 35.77 | 35.53 | 94.74 |
Diluted EPS Before Non-Recurring Items | NA | 0.26 | 0.24 | 0.25 | 0.23 |
Diluted Net EPS (GAAP) | NA | 0.22 | 0.34 | 0.29 | 0.11 |